Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TGIF2LX | hg38_v1_chrX_+_89921903_89921956 | 0.11 | 5.5e-01 | Click! |
MEIS3 | hg38_v1_chr19_-_47419490_47419538 | -0.10 | 5.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_47190013 Show fit | 4.29 |
ENST00000294338.7
|
PDZK1 interacting protein 1 |
|
chr17_+_42851167 Show fit | 3.80 |
ENST00000613571.1
ENST00000308423.7 |
amine oxidase copper containing 3 |
|
chr16_+_1240698 Show fit | 2.61 |
ENST00000561736.2
ENST00000338844.8 ENST00000461509.6 |
tryptase alpha/beta 1 |
|
chr16_-_1230089 Show fit | 2.56 |
ENST00000612142.1
ENST00000606293.5 |
tryptase beta 2 |
|
chr11_-_107719657 Show fit | 2.56 |
ENST00000525934.1
ENST00000531293.1 |
sarcolipin |
|
chr7_+_76510528 Show fit | 2.47 |
ENST00000334348.8
|
uroplakin 3B |
|
chr7_-_27152561 Show fit | 2.37 |
ENST00000467897.2
ENST00000612286.5 ENST00000498652.1 |
novel transcript homeobox A3 novel transcript |
|
chr16_+_29778252 Show fit | 2.25 |
ENST00000400752.6
|
zymogen granule protein 16 |
|
chr1_+_86468902 Show fit | 2.01 |
ENST00000394711.2
|
chloride channel accessory 1 |
|
chr9_-_22009272 Show fit | 1.99 |
ENST00000380142.5
ENST00000276925.7 |
cyclin dependent kinase inhibitor 2B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 4.7 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.6 | 3.8 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.1 | 3.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.0 | 3.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.2 | 3.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.9 | 2.6 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.3 | 2.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 2.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 2.1 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.2 | 2.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 4.3 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 3.8 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 3.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 2.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 2.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 2.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 2.0 | GO:0005903 | brush border(GO:0005903) |
0.2 | 1.7 | GO:0032010 | phagolysosome(GO:0032010) |
0.0 | 1.0 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 13.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.8 | 3.8 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.4 | 3.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 3.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 3.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 2.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.6 | 2.4 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.0 | 2.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 2.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 2.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 3.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 2.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 2.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 2.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 1.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |